Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 Colorectal Neoplasms 24 Carcinoma, Non-Small-Cell Lung 18 Rectal Neoplasms 14 Lung Neoplasms 13 Stomach Neoplasms 12 Esophageal Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Esophageal Squamous Cell Carcinoma 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 8 Neoplasm Metastasis 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Adenocarcinoma Of Esophagus 8 Ovarian Neoplasms 7 Sarcoma 6 Neoplasms 6 Head and Neck Neoplasms 6 Urinary Bladder Neoplasms 5 Osteosarcoma 5 Liver Neoplasms 5 Kidney Neoplasms 4 Inflammatory Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Carcinoma, Renal Cell 4 Breast Neoplasms, Male 4 Turcot syndrome 3 Multiple Myeloma 3 Locally Advanced Rectal Cancer 3

Interventions

Cyclophosphamide 58 Dexamethasone 50 Rituximab 39 Peripheral Blood Stem Cell Transplantation 29 Paclitaxel 29 Lenalidomide 28 fludarabine phosphate 27 Gemcitabine 26 Etoposide 26 Bortezomib 26 Cytarabine 25 Busulfan 24 pembrolizumab 21 Radiotherapy 21 Bevacizumab 21 Carboplatin 20 Mycophenolic Acid 19 Melphalan 19 Cisplatin 19 Filgrastim 18 pomalidomide 17 fludarabine 17 Oxaliplatin 17 Antilymphocyte Serum 17 Cyclosporine 16 Tacrolimus 15 Methotrexate 15 Whole-Body Irradiation 14 Methylprednisolone 13 Bendamustine Hydrochloride 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recurrence × Neoadjuvant Therapy × Clear all

NCT02572492 2018-08-17

CARFI

Aalborg University Hospital

Phase 2 Unknown

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡